Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

Hematologic

This is a Phase 2, randomized, multicenter study to evaluate the efficacy and safety of KD025 in subjects with Chronic Graft Versus Host Disease (cGVHD) after at least 2 prior lines of systemic therapy
Hematologic
II
Kitko, Carrie
NCT03640481
VICCCTT18121

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: